Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
111
111 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- RGH-202Phase 21 trial
Gedeon Richter Plc. · Social Anxiety Disorder
- RL-007InidascaminePhase 21 trial
Recognify Life Sciences · Cognitive Impairment Associated With Schizophrenia (CIAS), Cognitive Impairment, Schizophrenia
- SIPI6398Phase 21 trial
Shanghai Zhongze Therapeutics Co., Ltd. · Schizophrenia Disorder
- SOM001-APhase 21 trial
Somnum Pharma Inc. · Chronic Insomnia
- SOM001-BPhase 21 trial
Somnum Pharma Inc. · Chronic Insomnia
- SOM001-CPhase 21 trial
Somnum Pharma Inc. · Chronic Insomnia
- SOM001-DPhase 21 trial
Somnum Pharma Inc. · Chronic Insomnia
- SP-624Phase 21 trial
Sirtsei Pharmaceuticals, Inc. · Major Depressive Disorder
- SPN-821Phase 21 trial
Supernus Pharmaceuticals, Inc. · Major Depressive Disorder (MDD)
- SYT-510Phase 21 trial
Synendos Therapeutics AG · Generalized Anxiety Disorder
- VV119Phase 21 trial
Vigonvita Life Sciences · Schizophrenia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.